Burberry Shares Climb on Report of Potential Moncler Takeover Bid Anthropic Cofounder Chris Olah Warns Vatican AI Job Losses Pose Moral Imperative of Historic Proportions Indian Billionaires Accelerate Overseas Acquisitions Amid Domestic Growth Deceleration Trump Advises Caution in Iran Negotiations as Strait of Hormuz Reopening Considered Top Economist Tyler Cowen Says AIs Biggest Challenge Is Adjustment Not Unemployment AMD Pledges 10 Billion Investment in Taiwans AI and Semiconductor Ecosystem Paramount Gold Nevada Corp PZG Q1 2026 Earnings Significant EPS Miss amid PreRevenue Exploration Stage FXNC Q1 2026 Earnings EPS Misses Estimates Slightly Shares Edge Higher Agilent Technologies Q1 2026 Earnings EPS Falls Short of Consensus Shares Edge Higher CWCO Q1 2026 Earnings Earnings Miss Estimates Despite Positive Stock Movement SKIL Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher TAYD Q1 2026 Earnings Modest EPS Beat Drives Positive Stock Reaction ASTLW Surges Nearly 30 but Remains at Critical SupportResistance Level Avis Budget Group CAR Surges 592 as Volume and Sector Momentum Fuel Recovery United Parks Resorts PRKS Gains 26 as Stock Approaches Key Resistance Level Calamos Global Total Return Fund CGO Advances 192 Testing Key Resistance Zone Sound Point Meridian Capital Preferred Shares SPMA Edge Lower as Trading Remains RangeBound Pacific Northwest City Leads Home Price Declines as Housing Weakness Broadens TaoWeave Inc TWAV Q3 2022 Earnings Significant EPS Miss Sends Stock Lower Golden Entertainment GDEN Holds Steady at 2855 as Support and Resistance Levels Come into Focus Kemper Corporation KMPR Holds Near Resistance Amid Modest Gains WVVIP Preferred Stock Holds Steady at 267 as Support and Resistance Levels Solidify National Healthcare Properties Preferred Stock NHPAP Edges Lower in Quiet Trading NAPCO Security Technologies NSSC Gains 169 as Stock Tests Key Resistance BlackSky Technology BKSY Surges 528 Key Levels to Watch After Breakout Westlake Chemical Partners WLKP Holds Steady Near 225 Amid Narrow Trading Range Amphastar Pharmaceuticals AMPH Gains 14 as Stock Tests Resistance Near 2034